Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2020

Open Access 01-12-2020 | Research

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population

Authors: Ruxu You, Jinyu Liu, Zhihao Yang, Chenwei Pan, Qinghua Ma, Nan Luo

Published in: Health and Quality of Life Outcomes | Issue 1/2020

Login to get access

Abstract

Background

This study was conducted to compare the validity and discriminative power of both the EQ-5D-3 L and EQ-5D-5 L in an elderly Chinese population with multiple chronic and acute conditions.

Methods

A total of 648 retired people from China (mean ± standard deviation: 73.3 ± 6.4 years; male: 55.7%) were recruited and randomized to complete the 3 L or 5 L questionnaire. The 3 L and 5 L were compared in terms of distribution properties, ceiling effects, informativity, validity and discriminatory performance. Convergent validity between the 3 L and 5 L was tested by spearman’s rank-order correlation. Discriminatory power was conducted by relative efficiency as assessed by the F statistics.

Results

Most participants answered to “no problems” on both versions of EQ-5D. The 5 L trended towards a slightly lower ceiling compared with the 3 L. The Shannon index improved with the 5 L while the Shannon’s Evenness index tended to be similar. Convergent validity was confirmed by the moderate to strong correlation for both 3 L and 5 L. Relative efficiency suggested that 5 L had a higher absolute discriminatory power than the 3 L version in terms of the presence conditions, especially for osteoporosis and metabolic syndrome.

Conclusions

Both the 3 L and 5 L are demonstrated to be valid based HRQoL instruments in Chinese elderly population. The 5 L system may be preferable to the 3 L, as it demonstrated superior performance with respect to lower ceiling effect and better discriminatory power. Further research is needed to examine the responsiveness of the two EQ-5D instruments in this population.
Literature
1.
go back to reference EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
2.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef
3.
go back to reference Buchholz I, Janssen M. F, Kohlmann T, Feng YS. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018; 36(6): 645–661. Buchholz I, Janssen M. F, Kohlmann T, Feng YS. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018; 36(6): 645–661.
4.
go back to reference Yfantopoulos JN, Chantzaras AE. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. Eur J Health Econ. 2017;18(4):519–31.CrossRef Yfantopoulos JN, Chantzaras AE. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. Eur J Health Econ. 2017;18(4):519–31.CrossRef
5.
go back to reference Yfantopoulos J, Chantzaras A, Kontodimas S. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Arch Dermatol Res. 2017;309(5):357–70.CrossRef Yfantopoulos J, Chantzaras A, Kontodimas S. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Arch Dermatol Res. 2017;309(5):357–70.CrossRef
6.
go back to reference Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675–97.CrossRef Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675–97.CrossRef
7.
go back to reference Pan CW, Sun HP, Wang X, Ma Q, Xu Y, Luo N, Wang P. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Qual Life Res. 2015;24(7):1767–74.CrossRef Pan CW, Sun HP, Wang X, Ma Q, Xu Y, Luo N, Wang P. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Qual Life Res. 2015;24(7):1767–74.CrossRef
8.
go back to reference Wang P, Luo N, Tai E, Thumboo J. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg Issues. 2016;9:57–62.CrossRef Wang P, Luo N, Tai E, Thumboo J. The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with diabetes in Singapore. Value Health Reg Issues. 2016;9:57–62.CrossRef
9.
go back to reference Ferreira LN, Ferreira PL, Ribeiro FP, Pereira LN. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Health Qual Life Outcomes. 2016;14(1):89.CrossRef Ferreira LN, Ferreira PL, Ribeiro FP, Pereira LN. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Health Qual Life Outcomes. 2016;14(1):89.CrossRef
10.
go back to reference van Hout B, Janssen M, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard A. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–15.PubMed van Hout B, Janssen M, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard A. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–15.PubMed
11.
go back to reference Mulhern B, Feng Y, Shah K, Janssen MF, Herdman M, van Hout B, Devlin N. Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets. Pharmacoeconomics. 2018;36(6):699–713.CrossRef Mulhern B, Feng Y, Shah K, Janssen MF, Herdman M, van Hout B, Devlin N. Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets. Pharmacoeconomics. 2018;36(6):699–713.CrossRef
12.
go back to reference Luo N, Cheung YB, Ng R, Lee CF. Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores? Health Qual Life Outcomes. 2015;13(1):166.CrossRef Luo N, Cheung YB, Ng R, Lee CF. Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores? Health Qual Life Outcomes. 2015;13(1):166.CrossRef
13.
go back to reference Yang F, Devlin N, Luo N. Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments. Eur J Health Econ. 2019;20(1):99–105.CrossRef Yang F, Devlin N, Luo N. Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments. Eur J Health Econ. 2019;20(1):99–105.CrossRef
14.
go back to reference Yang Z, Busschbach J, Liu G, Luo N. EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes. 2018;16(1):210.CrossRef Yang Z, Busschbach J, Liu G, Luo N. EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes. 2018;16(1):210.CrossRef
15.
go back to reference Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662–9.CrossRef Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662–9.CrossRef
16.
go back to reference Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604.CrossRef Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604.CrossRef
17.
go back to reference Sun S, Chen J, Kind P, Xu L, Zhang Y, Burström K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res. 2015;24(3):693–703.CrossRef Sun S, Chen J, Kind P, Xu L, Zhang Y, Burström K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res. 2015;24(3):693–703.CrossRef
18.
go back to reference Zhao L, Liu X, Liu D, He Y, Liu Z, Li N. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China. Medicine. 2019;98(11):e14719.CrossRef Zhao L, Liu X, Liu D, He Y, Liu Z, Li N. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China. Medicine. 2019;98(11):e14719.CrossRef
19.
go back to reference Gu Y, Zhang H, Ali SH, Huang M, Wei J, Gu S, Zhen X, Hu X, Sun X, Dong H. Social determinants of health-related quality of life among residents in Zhejiang and Qinghai, China. Int J Environ Res Public Health. 2019;16(8):1–14.CrossRef Gu Y, Zhang H, Ali SH, Huang M, Wei J, Gu S, Zhen X, Hu X, Sun X, Dong H. Social determinants of health-related quality of life among residents in Zhejiang and Qinghai, China. Int J Environ Res Public Health. 2019;16(8):1–14.CrossRef
20.
go back to reference Martí-Pastor M, Pont A, Ávila M, Garin O, Vilagut G, Forero CG, Pardo Y, Tresserras R, Medina-Bustos A, Garcia-Codina O, Cabasés J, Rajmil L, Alonso J, Ferrer M. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys. Popul Health Metrics. 2018;16(1):14.CrossRef Martí-Pastor M, Pont A, Ávila M, Garin O, Vilagut G, Forero CG, Pardo Y, Tresserras R, Medina-Bustos A, Garcia-Codina O, Cabasés J, Rajmil L, Alonso J, Ferrer M. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys. Popul Health Metrics. 2018;16(1):14.CrossRef
21.
go back to reference Feng Y, Devlin N, Herdman M. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes. 2015;13:171.CrossRef Feng Y, Devlin N, Herdman M. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes. 2015;13:171.CrossRef
22.
go back to reference Craig BM, Pickard AS, Lubetkin EI. Health problems are more common, but less severe when measured using newer EQ-5D versions. J Clin Epidemiol. 2014;67(1):93–9.CrossRef Craig BM, Pickard AS, Lubetkin EI. Health problems are more common, but less severe when measured using newer EQ-5D versions. J Clin Epidemiol. 2014;67(1):93–9.CrossRef
23.
go back to reference Kim TH, Jo MW, Lee SI, Kim SH, Chung SM. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013;22(8):2245–53.CrossRef Kim TH, Jo MW, Lee SI, Kim SH, Chung SM. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013;22(8):2245–53.CrossRef
24.
go back to reference Fu AZ, Kattan MW. Racial and ethnic differences in preference-based health status measure. Curr Med Res Opin. 2006;22(12):2439–48.CrossRef Fu AZ, Kattan MW. Racial and ethnic differences in preference-based health status measure. Curr Med Res Opin. 2006;22(12):2439–48.CrossRef
25.
go back to reference Buchholz I, Thielker K, Feng YS, Kupatz P, Kohlmann T. Measuring changes in health over time using the EQ-5D 3L and 5L: a head-to-head comparison of measurement properties and sensitivity to change in a German inpatient rehabilitation sample. Qual Life Res. 2015;24(4):829–35.CrossRef Buchholz I, Thielker K, Feng YS, Kupatz P, Kohlmann T. Measuring changes in health over time using the EQ-5D 3L and 5L: a head-to-head comparison of measurement properties and sensitivity to change in a German inpatient rehabilitation sample. Qual Life Res. 2015;24(4):829–35.CrossRef
26.
go back to reference Poór AK, Rencz F, Brodszky V, Gulácsi L, Beretzky Z, Hidvégi B, Holló P, Kárpáti S, Péntek M. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual Life Res. 2017;26(12):3409–19.CrossRef Poór AK, Rencz F, Brodszky V, Gulácsi L, Beretzky Z, Hidvégi B, Holló P, Kárpáti S, Péntek M. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual Life Res. 2017;26(12):3409–19.CrossRef
27.
go back to reference Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015;13(1):14.CrossRef Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015;13(1):14.CrossRef
28.
go back to reference Janssen M, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–27.CrossRef Janssen M, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–27.CrossRef
29.
go back to reference Janssen MF, Birnie E, Haagsma JA, Bonsel GJ. Comparing the standard EQ-5D three-level system with a five-level version. Value Health. 2008;11(2):275–84.CrossRef Janssen MF, Birnie E, Haagsma JA, Bonsel GJ. Comparing the standard EQ-5D three-level system with a five-level version. Value Health. 2008;11(2):275–84.CrossRef
30.
go back to reference Golicki D, Niewada M, van Hout B, Janssen M, Pickard AS. Interim EQ-5D-5L value set for Poland: first crosswalk value set in central and Eastern Europe. Value Health Reg Issues. 2014;4:19–23.PubMed Golicki D, Niewada M, van Hout B, Janssen M, Pickard AS. Interim EQ-5D-5L value set for Poland: first crosswalk value set in central and Eastern Europe. Value Health Reg Issues. 2014;4:19–23.PubMed
Metadata
Title
Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
Authors
Ruxu You
Jinyu Liu
Zhihao Yang
Chenwei Pan
Qinghua Ma
Nan Luo
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2020
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-020-01324-0

Other articles of this Issue 1/2020

Health and Quality of Life Outcomes 1/2020 Go to the issue